MJ And MSOS: Cannabis' Inevitable Legalization Offers High Upside Despite Blunt Risks
Cannabis legalization is inevitable, driven by shifting political, generational, and fiscal dynamics, especially as Republicans seek votes and tax revenue. Despite high risks, the upside for cannabis ETFs like MJ and MSOS is compelling, making them suitable for risk capital allocations. Demographic trends and bipartisan support suggest federal decriminalization is only a matter of time, further boosting the industry's long-term prospects.
Sell MSOS And Its 3 Largest Holdings
I am downgrading MSOS (and its top holdings to Strong Sell or Sell), to Strong Sell due to ongoing 280E taxation concerns and poor market performance. MSOS has seen significant redemptions since March and trading volume declines, with its shares outstanding increasing only 1.2% year-to-date amidst a 32.8% price drop. Despite low valuations, high debt levels and negative EPS projections for 2025 make Curaleaf and Trulieve risky investments.
MSOS: High Risk/Reward On The Cannabis Market
The AdvisorShares Pure US Cannabis ETF offers a high-risk/high-reward opportunity, especially if cannabis is rescheduled to Schedule III in 2025. MSOS is an actively managed ETF focused on US cannabis companies, with potential growth as more states legalize cannabis. Federal legislative changes, particularly rescheduling cannabis, could significantly boost MSOS, but the ETF faces risks like redemptions and legislative setbacks.
New Thematic ETF Focuses on HVAC Companies & Industrials
On Tuesday, AdvisorShares launched the AdvisorShares HVAC and Industrials ETF (HVAC), the newest fund to join the AdvisorShares fund library. HVAC is an actively managed thematic fund that looks to provide capital appreciation over the long term.
MSOS Has Crashed But May Rebound
AdvisorShares Pure US Cannabis ETF has plummeted 65% since last year, with recent declines driven by Florida's failed legalization vote and MJUS liquidation news. MSOS remains poorly diversified, with top holdings Green Thumb Industries, Trulieve, and Curaleaf now representing 70% of the fund, raising concerns about its weighting. Potential redemptions could further pressure MSOS, but eliminating 280E taxation might improve financials and sentiment, offering a possible bounce.
Navigating Volatility: MSOS ETF's Prospects In A Shifting Cannabis Landscape
The AdvisorShares Pure US Cannabis ETF offers targeted exposure to the U.S. cannabis industry, focusing on growth and value stocks despite recent volatility. Key catalysts include Biden's cannabis rescheduling efforts, the SAFER Banking Act, and the 2024 U.S. Presidential Election, with both candidates supporting cannabis reform. Despite regulatory uncertainties and market volatility, the ETF's discounted valuations and high-growth potential present compelling investment opportunities.
Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence.
AI stocks have been phenomenal investments in recent years, but investors are paying a high price for them today. Growth investors can generate better returns by targeting undervalued stocks that may have more upside.
MSOS: Opportunity And Frustration Ahead
Cannabis demand is high, but investing challenges hinder industry growth due to lack of federal framework. AdvisorShares Pure US Cannabis ETF focuses on US-based cannabis companies, excluding Canadian exposures. MSOS is a basket of top-tier US cannabis companies using swap agreements due to lack of federal legalization, with high concentration and potential volatility.
Waiving ETF Expense Fees: How and Why
Traditionally, ETF investors expect to face expense ratios to compensate fund providers and managers for their investments. However, that is not always the case.
MSOS: The Dominos Are Falling
AdvisorShares Pure US Cannabis ETF invests in the cannabis industry through direct investments and derivatives. The top holdings of the ETF include Green Thumb Industries, Curaleaf Holdings, Trulieve Cannabis, and Verano Holdings. The industry stands to benefit greatly from the removal of the 280e tax obligation due to rescheduling from 3 to 1.
